Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.600

-8.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Druss who wrote (3870)	9/21/1999 10:03:00 PM
From: out_of_the_loop	Read Replies (1) of 10293

<<<Marconi brought out some aspects of the study that has been mentioned here that I would like to question in more detail. Specifically as reported the study is relying on self diagnosing of the test population as to whether they have colds or not. This is a badly flawed model. >>> <<etc, etc>> Fact is this, Druss, plain and simple. This study was modeled after the first Quigley study to the letter. Period. That got published now didn't it? Why was it done that way? Because at the time it was developed, Zicam had only one competition: Quigley. So, it made sense to copy their study using a different remedy to see what the results were in comparison. All the criticisms of the first study will be answered in the second one - conducted similarly to the Tremacamra study published in JAMA this year. So, criticize the model all you want - there was a reason for it. How do I know? I asked. It was that simple.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next